Thompson Street Capital Partners Makes Growth Investment in Sabai Global
February 6, 2023
Thompson Street Capital Partners (TSCP) completed a growth investment in Sabai Global, a Chesterfield, Missouri-based provider of biosafety consulting, regulatory review, and central IRB services for clinical research. The investment will support Sabai’s continued expansion of services—particularly in cell and gene therapy—across pharmaceutical sponsors, CROs, academic health systems, and clinical research site networks.
- Buyers
- Thompson Street Capital Partners
- Targets
- Sabai Global
- Industry
- Healthcare Services
- Location
- Missouri, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Thompson Street Capital Partners Makes Growth Investment in OpenClinica
February 21, 2023
Healthcare Services
Thompson Street Capital Partners (TSCP) has completed a growth investment in OpenClinica, a Waltham, Massachusetts–based cloud-first eClinical platform that automates clinical data capture and integrates with EHRs. The investment will support OpenClinica’s expansion of its Unite EHR-connected network and the company’s broader product and market growth; terms were not disclosed.
-
Thompson Street Capital Partners Makes Growth Investment in Silverchair
August 11, 2022
Cloud & SaaS
Thompson Street Capital Partners (TSCP) completed a growth investment in Silverchair, the Charlottesville-based content management and digital platform for scholarly and professional publishers. The partnership will provide capital to accelerate Silverchair's growth and expand its product and service capabilities for associations, societies, and STM publishers; financial terms were not disclosed.
-
Thompson Street Capital Partners Acquires LifeSpan Biosciences (LSBio)
September 17, 2018
Biotechnology
Thompson Street Capital Partners (TSCP), a St. Louis-based private equity firm, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc. (LSBio), a developer and e‑commerce distributor of antibodies, kits, proteins and related reagents for academic and pharmaceutical research. TSCP said it will support LSBio's strategy to expand its catalog and capabilities organically and via targeted acquisitions; terms were not disclosed.
-
Thompson Street Capital Partners Makes Growth Investment in Green Mountain Technology
February 24, 2020
Logistics & Distribution
Thompson Street Capital Partners (TSCP) has completed a growth investment in Green Mountain Technology, LLC (GMT), a Memphis-based provider of parcel spend management solutions. Terms were not disclosed; TSCP will partner with GMT’s leadership to accelerate product development, expand offerings and scale the business.
-
Thompson Street Capital Partners Recapitalizes Benefit Recovery Group
August 3, 2022
Healthcare Services
Thompson Street Capital Partners (TSCP) has made a growth investment/recapitalization in Benefit Recovery Group (BRG), a Memphis-based provider of health plan subrogation and compensation recovery services. The partnership will support BRG’s sales force expansion, rollout of additional services and M&A-driven growth; terms were not disclosed and Edgemont Partners acted as BRG’s exclusive financial advisor.
-
Thompson Street Capital Partners Invests in ATIS
September 25, 2024
Engineering Services
Thompson Street Capital Partners (TSCP) has made a growth investment in ATIS, a St. Louis–headquartered provider of elevator and escalator safety inspections, consulting, and managed services. Terms were not disclosed; TSCP said the capital will support expansion of ATIS’ service offerings, sales and marketing, geographic growth, and strategic add-on acquisitions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.